SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/14/21 Cyclo Therapeutics, Inc. 10-Q 3/31/21 39:2.2M RDG Filings/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 222K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 18K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 18K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 14K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 14K 12: R1 Document And Entity Information HTML 45K 13: R2 Consolidated Balance Sheets (Current Period HTML 89K Unaudited) 14: R3 Consolidated Balance Sheets (Current Period HTML 24K Unaudited) (Parentheticals) 15: R4 Consolidated Statements of Operations (Unaudited) HTML 69K 16: R5 Consolidated Statements of Stockholders' Equity HTML 45K (Unaudited) 17: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 80K 18: R7 Note 1 - Summary of Significant Accounting HTML 53K Policies 19: R8 Note 2 - Revenues HTML 32K 20: R9 Note 3 - Major Customers and Suppliers HTML 18K 21: R10 Note 4 - Mortgage Note Receivable HTML 16K 22: R11 Note 5 - Note Payable HTML 16K 23: R12 Note 6 - Equity Transactions HTML 28K 24: R13 Note 7 - Income Taxes HTML 18K 25: R14 Note 8 - Equity Incentive Plan HTML 16K 26: R15 Note 9 - Subsequent Events HTML 16K 27: R16 Significant Accounting Policies (Policies) HTML 100K 28: R17 Note 2 - Revenues (Tables) HTML 26K 29: R18 Note 1 - Summary of Significant Accounting HTML 27K Policies (Details Textual) 30: R19 Note 2 - Revenues (Details Textual) HTML 20K 31: R20 Note 2 - Revenues - Revenues by Product (Details) HTML 25K 32: R21 Note 3 - Major Customers and Suppliers (Details HTML 29K Textual) 33: R22 Note 4 - Mortgage Note Receivable (Details HTML 20K Textual) 34: R23 Note 5 - Note Payable (Details Textual) HTML 14K 35: R24 Note 6 - Equity Transactions (Details Textual) HTML 133K 36: R25 Note 8 - Equity Incentive Plan (Details Textual) HTML 23K 38: XML IDEA XML File -- Filing Summary XML 61K 37: EXCEL IDEA Workbook of Financial Reports XLSX 38K 6: EX-101.INS XBRL Instance -- ctdh-20210331 XML 507K 8: EX-101.CAL XBRL Calculations -- ctdh-20210331_cal XML 77K 9: EX-101.DEF XBRL Definitions -- ctdh-20210331_def XML 601K 10: EX-101.LAB XBRL Labels -- ctdh-20210331_lab XML 512K 11: EX-101.PRE XBRL Presentations -- ctdh-20210331_pre XML 604K 7: EX-101.SCH XBRL Schema -- ctdh-20210331 XSD 90K 39: ZIP XBRL Zipped Folder -- 0001437749-21-012317-xbrl Zip 75K
Download this Microsoft® Excel® .xlsx workbook |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/18/21 Cyclo Therapeutics, Inc. 424B5 1:264K RDG Filings/FA 11/16/21 Cyclo Therapeutics, Inc. 424B5 1:265K RDG Filings/FA 8/16/21 Cyclo Therapeutics, Inc. 424B5 1:242K RDG Filings/FA 5/21/21 Cyclo Therapeutics, Inc. S-3/A 2:236K RDG Filings/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/10/20 Cyclo Therapeutics, Inc. 8-K:3,5,9 11/06/20 4:1.2M RDG Filings/FA |